These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23449122)

  • 1. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
    Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
    Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.
    Jia Y; Yang Y; Brock MV; Zhan Q; Herman JG; Guo M
    J Pathol; 2013 Jun; 230(2):194-204. PubMed ID: 22806826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
    Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
    Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
    Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
    PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
    Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
    Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.
    Zhang M; Linghu E; Zhan Q; He T; Cao B; Brock MV; Herman JG; Xiang R; Guo M
    Oncotarget; 2016 Apr; 7(14):17957-69. PubMed ID: 26919254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.
    Li J; Zhang M; He T; Li H; Cao T; Zheng L; Guo M
    Sci Rep; 2017 Jun; 7(1):3325. PubMed ID: 28607412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing.
    Gao S; Yang Z; Zheng ZY; Yao J; Zhang F; Wu LM; Xie HY; Zhou L; Zheng SS
    World J Surg Oncol; 2013 Mar; 11():57. PubMed ID: 23496880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
    BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
    Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
    Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.
    Fan J; Zhang Y; Mu J; He X; Shao B; Zhou D; Peng W; Tang J; Jiang Y; Ren G; Xiang T
    Clin Epigenetics; 2018 Aug; 10(1):103. PubMed ID: 30075814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and epigenetic regulation of DACT1 and DACT2 in oral squamous cell carcinoma.
    Schussel JL; Kalinke LP; Sassi LM; de Oliveira BV; Pedruzzi PA; Olandoski M; Alvares LE; Garlet GP; Trevilatto PC
    Cancer Biomark; 2015; 15(1):11-7. PubMed ID: 25524937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
    J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.